Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Nasdaq, Inc. reports Q3 results on October 22 with the stock down 4.8% over the past month, a mild target-price trim from Barclays arriving this morning, and an activist holder still on the register from a filing last year.
The lending market is entirely relaxed, and that is worth stating clearly before anything else. Short interest is 1.4% of the free float, a low and largely unremarkable level, and availability is at the maximum reading in the system with roughly 554 million shares available to borrow. Borrowing costs are a nominal 0.35%. The short-score has drifted up to 30.5 from 28.8 in late September, but that is a gentle creep, not a directional signal. What is more telling is the options market: the put/call ratio has dropped to 0.49, well below its 20-day average of 0.54 and closer to the 52-week low of 0.29 than the high of 1.03. Call flow is dominating, not the hedging posture you would expect from investors bracing for a difficult print.
Analyst sentiment is constructive, if quietly cautious on valuation. Barclays' Benjamin Budish trimmed his target this morning from $111 to $109 while holding an Overweight rating, a recalibration rather than a change of view. Earlier in the week, Piper Sandler raised its target from $104 to $108, also maintaining Overweight. Wells Fargo initiated coverage on October 2 at Equal-Weight with a $100 target, planting a flag at the more sceptical end of the range. The mean target across the Street is $109, about 18% above the current price of $92.27. The bull case centres on the 14% year-over-year lift in Market Services revenue and roughly 25% growth in Financial Crime Management Technology. Bears point to a projected 10% decline in FY26 EPS, persistent softness in IPO activity, and integration risk from the Adenza acquisition. The P/E has compressed about 1.2 points over 30 days to just above 20x, and the EV/EBITDA of 16x has also eased slightly, reflecting the month's price weakness rather than any earnings revision.
The activist angle is worth flagging, even if it is a historical footnote rather than a live catalyst. Argus Seller LP filed a Schedule 13D in May 2025, a filing type that signals active rather than passive intent. Its most recent disclosed stake is 4.44%, already below the 5% threshold that triggers ongoing reporting obligations, and the filing dates to more than 16 months ago. Under SEC rules, a holder that falls below 5% may not file again, so the current position is unknown. The standard caveat applies: stakes are as-last-disclosed around the 5% threshold. Separately, Wellington Management filed a 13G/A amendment in August disclosing a 5.4% stake, down from 7.2% previously. The direction of that reduction, combined with Vanguard's separate entity filing a 6.29% stake in April while the original Vanguard Group entity reported falling to 0%, points to some reshuffling in the passive ownership base rather than a clean exit.
Insider activity over the past 90 days runs entirely one way. Net sales of roughly 57,000 shares totalled about $5.4 million, with the CIO selling $1.2 million in late July and the President of Capital Access Platforms selling more than $2 million across two transactions in late July and early August. Most of the CSO's activity was under a pre-arranged 10b5-1 plan, which reduces its signal value considerably. The CIO and the Capital Access Platforms president sold outside plan structures, making those transactions marginally more informative, though the amounts are not large relative to the company's scale.
The most recent quarterly print, filed in late July, produced a 1.3% next-day gain and a 4.7% five-day gain. That is a constructive recent reaction pattern, though one data point is a thin base. The October 22 print lands with the stock still 4.8% below its month-ago level, call buyers in control of the options market, and a Street consensus that sits well above current levels. What the print will need to show is whether the Financial Crime Technology growth rate held, and whether IPO activity showed any recovery after a prolonged lull.
See the live data behind this article on ORTEX.
Open NDAQ on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
